BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8915030)

  • 1. Abnormal signal transduction through CD4 leads to altered tyrosine phosphorylation in T cells derived from MRL-lpr/lpr mice.
    Duan JM; Fagard R; Madaio MP
    Autoimmunity; 1996; 23(4):231-43. PubMed ID: 8915030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling.
    Kanda H; Mimura T; Hamasaki K; Yamamoto K; Yazaki Y; Hirai H; Nojima Y
    Immunology; 1999 May; 97(1):56-61. PubMed ID: 10447714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for kinase activity of CD4-associated p56lck in antibody-triggered T cell signal transduction.
    Chu K; Littman DR
    J Biol Chem; 1994 Sep; 269(39):24095-101. PubMed ID: 7929062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
    Budd RC; Winslow G; Inokuchi S; Imboden JB
    J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice.
    Mimura T; Minota S; Nojima Y; Morino N; Hamasaki K; Furuya H; Yazaki Y
    J Immunol; 1997 Mar; 158(6):2977-83. PubMed ID: 9058837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation.
    Zielinski CE; Jacob SN; Bouzahzah F; Ehrlich BE; Craft J
    J Immunol; 2005 Apr; 174(8):5100-9. PubMed ID: 15814741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
    J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties.
    Kakkanaiah VN; Nagarkatti M; Nagarkatti PS
    Cell Immunol; 1990 May; 127(2):442-57. PubMed ID: 2139366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective signal-transduction pathways in T-cells from autoimmune MRL-lpr/lpr mice are associated with increased polyamine concentrations.
    Thomas TJ; Gunnia UB; Seibold JR; Thomas T
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):175-82. PubMed ID: 7575451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 2B4-mediated signals in the pathogenesis of a murine hepatitis model independent of Fas and Valpha14 NKT cells.
    Furukawa H; Kitazawa H; Kaneko I; Matsubara M; Nose M; Ono M
    Immunology; 2009 Sep; 128(1 Suppl):e151-8. PubMed ID: 18800987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3 expression, modulation and signalling in T-cell subpopulations from MRL/Mp-lpr/lpr mice.
    Davignon JL; Arnold LW; Cohen PL; Eisenberg RA
    J Autoimmun; 1991 Dec; 4(6):831-44. PubMed ID: 1839879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice.
    Ohteki T; Seki S; Abo T; Kumagai K
    J Exp Med; 1990 Jul; 172(1):7-12. PubMed ID: 2141631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase activity of CD4-associated p56lck may not be required for CD4-dependent T-cell activation.
    Collins TL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11885-9. PubMed ID: 7505449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Lck Src homology 2 and 3 domains in protein tyrosine phosphorylation.
    Lee-Fruman KK; Collins TL; Burakoff SJ
    J Biol Chem; 1996 Oct; 271(40):25003-10. PubMed ID: 8798782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinase-dependent function of Lck in T-cell activation requires an intact site for tyrosine autophosphorylation.
    Xu H; Littman DR
    Ann N Y Acad Sci; 1995 Sep; 766():99-116. PubMed ID: 7486706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
    Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
    J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burek CL; Hu Q; Kuppers RC; Lee B; Prendergast RA
    Cell Immunol; 1992 May; 141(2):496-507. PubMed ID: 1576659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.